WHITESTOWN, Ind. (WISH) - A company that's already promised more than a thousand newbio-tech jobs in Central Indiana has just sweetened the deal.
Medco Health Solutions already has anoperation under construction off Interstate 65 in Whitestown. Rightnow, the only signs of life there are the construction workers andthe geese swimming in the pond out front.
But in the coming months, people will work inside the buildingas pharmacists, researchers and engineering technologists.
Rich Jones is the vice president and general manager ofMedco's Whitestown facility. Tuesday, the mail-order pharmacycompany announced the operation will employ 160 people more thanoriginally planned. The employees will work in an oncologytherapeutic resource center.
The workers will do more than the typical pharmacist,according to Jones.
"Not just getting them the right drug, but also making surethey're making the lifestyle changes, choices that they canmaximize the use of their drugs and have better outcomes with theironcology therapy," said Jones.
Medco said it feels confident it can fill the positions withhigh-quality pharmacists. The plant is located between two goodpharmacy schools: Purdue University to the north and ButlerUniversity to the south.
"Yes, we think with the two schools of pharmacy and then you'vealso got Indiana University's medical research center that we canwork with, there are a lot of good folks and good things that wecan do to continue to grow this business," said Jones.
The oncology section of the operation should be up and runningby October of 2009.
More employees will come online at the beginning of next year.Altogether, the company expects to employ between 1,200 and 1,400people -- a bright spot in dark economic times.
Governor Daniels said the additional jobs at Medco are fabulousnews. He said in total payroll dollars, Medco was already thebiggest new company the state has recruited. The governor said theexpansion will add tens of millions dollars more to the state'seconomy.
University officials had planned a $4 million demolition of the Statesman Towers over the school's winter break.
Eli Lilly said Thursday its depression drug edivoxetine failed in late-stage clinical testing, and it doesn't plan to file for marketing approval of the drug.
A groundbreaking ceremony is planned for Dec. 12 at the Willard Library just north of the city's downtown to mark the beginning of work on the $2.4 million project.